Octavia Wealth Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$707K Sell
29,381
-9,686
-25% -$253K 0.06% 95
2026
Q1
$1.1M Sell
39,067
-890
-2% -$23.7K 0.1% 68
2025
Q4
$990K Buy
39,957
+2,312
+6% +$58.3K 0.09% 82
2025
Q3
$959K Buy
37,645
+15,393
+69% +$380K 0.1% 87
2025
Q2
$539K Sell
22,252
-3,532
-14% -$82.4K 0.06% 110
2025
Q1
$653K Buy
25,784
+3,625
+16% +$94.9K 0.08% 97
2024
Q4
$588K Buy
22,159
+7,319
+49% +$199K 0.07% 101
2024
Q3
$429K Sell
14,840
-1,289
-8% -$37.6K 0.05% 133
2024
Q2
$451K Buy
16,129
+868
+6% +$23.9K 0.06% 129
2024
Q1
$423K Sell
15,261
-933
-6% -$25.9K 0.06% 131
2023
Q4
$466K Buy
16,194
+162
+1% +$4.9K 0.08% 124
2023
Q3
$532K Buy
16,032
+3,082
+24% +$109K 0.11% 100
2023
Q2
$475K Buy
12,950
+1,951
+18% +$75.9K 0.1% 106
2023
Q1
$449K Buy
10,999
+341
+3% +$14.7K 0.1% 98
2022
Q4
$546K Buy
10,658
+1,423
+15% +$68.2K 0.13% 85
2022
Q3
$404K Buy
9,235
+44
+0.5% +$2.14K 0.11% 99
2022
Q2
$480K Buy
9,191
+2,158
+31% +$110K 0.13% 94
2022
Q1
$364K Sell
7,033
-179
-2% -$9.29K 0.08% 124
2021
Q4
$426K Sell
7,212
-1,328
-16% -$65.8K 0.09% 116
2021
Q3
$367K Buy
8,540
+1,408
+20% +$62.4K 0.09% 117
2021
Q2
$279K Buy
7,132
+364
+5% +$14.2K 0.07% 139
2021
Q1
$245K Sell
6,768
-1,210
-15% -$43K 0.07% 151
2020
Q4
$294K Buy
+7,978
New +$293K 0.1% 129

Other funds holding PFE

Octavia Wealth Advisors's PFE Position: Q2 2026 in Review

Octavia Wealth Advisors reduced its Pfizer (PFE) stake by 25% in Q2 2026, selling an estimated $253K and leaving 29,381 shares worth $707K. The position accounts for 0.06% of the portfolio, ranked #95.

Octavia Wealth Advisors first reported a position in PFE in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.1M in Q1 2026. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Octavia Wealth Advisors held 29,381 shares of Pfizer worth $707K as of Q2 2026.
  • Octavia Wealth Advisors sold 9,686 Pfizer shares in Q2 2026, an estimated $253K.
  • Pfizer made up 0.06% of Octavia Wealth Advisors's portfolio in Q2 2026, its #95 holding.
  • Octavia Wealth Advisors first reported a position in Pfizer in Q4 2020 and has held it in 23 quarters since.
  • Octavia Wealth Advisors's Pfizer position peaked at $1.1M in Q1 2026.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Octavia Wealth Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.